Home
Resources
Publications
Harpagide Inhibits Neuronal Apoptosis and Promotes Axonal Regeneration After Spinal Cord Injury in Rats by Activating the Wnt/β-catenin Signaling Pathway

Harpagide Inhibits Neuronal Apoptosis and Promotes Axonal Regeneration After Spinal Cord Injury in Rats by Activating the Wnt/β-catenin Signaling Pathway

Yuluo Rong, Wei Liu, Zheng Zhou, Fangyi Gong, Jianling Bai, Jin Fan, Linwei Li, Yongjun Luo, Zhimin Zhou, Weihua Cai

Brain Res Bull. 2019 May;148:91-99.

PMID: 30940474

Abstract:

The neuronal apoptosis program associated with spinal cord injury (SCI) has a severe impact on spinal cord function, which leads to further secondary and permanent neuronal damage that may cause irreparable damage to the central nervous system. Activation of the Wnt/β-catenin signaling pathway is effective in reducing apoptosis and preventing SCI. Harpagide is one of the main active constituents of the iridoid class of molecules, which have neuroprotective effects after SCI. In this study, we demonstrated that harpagide attenuated neuronal apoptosis via activation of the Wnt/β-catenin signaling pathway. This resulted in a promotion of axonal regeneration and an inhibition of glial scar formation, which ultimately improved functional behavioral recovery after SCI in rats. Specifically, the administration of harpagide after SCI increased the expression levels of β-catenin, c-myc and cyclin D1 proteins in spinal cord neurons, as well as increased the number of motor neurons and reduced the size of the SCI lesion area. In addition, the administration of harpagide after SCI also decreased the protein expression levels as well as the number of cells immuno-stained for the pro-apoptotic proteins Bax and cleaved-caspase 3. The expression level of the anti-apoptotic protein Bcl-2 was also increased. When the Wnt /β-catenin signaling pathway was inhibited, a weakened anti-apoptotic effect of harpagide was observed. Additionally, the application of harpagide led to an increase in NF200 staining and a reduction in GFAP staining in the SCI injury site. In summary, our study suggested that harpagide may be a promising drug for the treatment of SCI.

Chemicals Related in the Paper:

Catalog Number	Product Name	Structure	CAS Number	Price
AP6926085	Harpagide		6926-08-5	Price

As a specialist in analytical chemical Products, Alfa Chemistry offers consumers a wealth of raw materials and a full range of technologies and services.

QUICK LINKS

HEADQUARTERS

Tel:

Fax:

Email: